Oncoscope is now available on iPad

Request free access to get started

Oncoscope logo updated
Contact
Log in
Request free access
Publications
100% sourced from leading minds on the front lines of oncology treatment
News & Insights
Publications
ISPOR 2026

May 17 – 20 | Philadelphia, PA

18 presentations. One mission
View posters

Latest Publications

EHA 2026
Advancing personalized management in multiple myeloma: the untapped value of minimal residual disease-guided treatment
Musat M, Rege J, Liu R, et al. Advancing personalized management in multiple myeloma: the untapped value of minimal residual disease-guided treatment [abstract PB3356]. HemaSphere.
In press
ESMO RWD 2026
Development and Validation of an Agentic AI-Augmented Living Decision Support Tool for Oncology: A Breast Cancer Pilot Study
Rugo H, Forsythe A, Flora D, et al. Development and validation of an agentic AI-augmented living decision support tool for oncology: A breast cancer pilot study. ESMO Real World Data Digital Oncol.
In press
SABCS 2025
Development and Validation of a Living Decision Support Tool (Living-DST) in Oncology Using Agentic AI-Augmented Systematic Literature Review (SLR)
Schwartzberg L, Forsythe A, Flora D, et al. Development and validation of a living decision support tool in oncology using agentic AI-augmented systematic literature review [abstract PS3-04-10]. Clin Cancer Res. 2026;32(4 Suppl):PS3-04-10. doi:10.1158/1557-3265.SABCS25-PS3-04-10
See Publication
ESMO AI 2025
Development and Validation of a Living Decision Support Tool (Living-DST) in Non-Small Cell Lung Cancer (NSCLC) Using Agentic AI-Augmented Systematic Literature Review (SLR)
Borghaei H, Forsythe A, Rege J, Liu R, Reck M. Development and validation of a living decision support tool (Living-DST) in non-small cell lung cancer (NSCLC) using agentic AI-augmented systematic literature review (SLR) [abstract 281P]. Ann Oncol. 2025;36(10 suppl):1-153. 10.1016/esmorw/esmorw100199
See Publication
WCLC 2025
Living Systematic Review Linked to Guidelines and Regulatory Approvals as a Treatment Decision Support Tool in NSCLC
Borghaei H, Forsythe A, Grieve S, Liu R, Rege JM, Sarkisian S. Living systematic review linked to guidelines and regulatory approvals as a treatment decision support tool in NSCLC [abstract P1.17.78]. J Thorac Oncol. 2025;20(10 S1):S250-S251. doi:10.1016/j.jtho.2025.09.463
See Publication
ASCO Annual 2025
Comprehensive decision support tool (DST) in breast cancer: Automated National Comprehensive Cancer Network (NCCN) guidelines linked to living systematic literature review (SLR)
Kaufman PA, Forsythe A, Liu R, Rege J, Cortes J. Comprehensive decision support tool (DST) in breast cancer: automated National Comprehensive Cancer Network (NCCN) guidelines linked to living systematic literature review (SLR) [abstract]. J Clin Oncol. 2025;43:e13676. doi:10.1200/JCO.2025.43.16_suppl.e13676
See Publication
NCCN Annual 2025

Real-Time Clinical Trial Data Library in Non-Small Cell Lung (NSCLC), Prostate (PC), and Breast Cancer (BC) to Support Informed Treatment Decisions: Now a Reality With a Fine-Tuned Large Language Model (LLM)

Liu RJ, Forsythe A, Rege JM, Kaufman PA. Real-time clinical trial data library in non-small cell lung (NSCLC), prostate (PC), and breast cancer (BC) to support informed treatment decisions: now a reality with a fine-tuned large language model (LLM) [abstract]. J Natl Compr Canc Netw. 2025;23(3.5):BIO25-024. doi: 10.6004/jnccn.2024.7156
See Publication
ASCO Annual 2025
A living systematic literature review (L-SLR) for non–small-cell lung (NSCLC), prostate (PC), and breast cancer (BC), built with an agentic text annotation system powered by large language models (LLM) to assist treatment decision making
Sarkisian S, Liu RJ, Liu E, Forsythe A. A living systematic literature review (L-SLR) for non–small-cell lung (NSCLC), prostate (PC), and breast cancer (BC), built with an agentic text annotation system powered by large language models (LLM) to assist treatment decision making [abstract]. J Clin Oncol. 2025;43:e13677. doi:10.1200/JCO.2025.43.16_suppl.e1365
See Publication

More publications by Oncoscope-AI leadership

  1. Liu R, Mosselman JJ, Hanegraaf P, van der Schans J, Rizzo M, Forsythe A. SA24 Can an Integrated Systematic Literature Review (SLR) Database Improve the Speed of Title and Abstract (TIAB) Review? A Case Study Using Multiple Myeloma (MM) Projects in Interventional and Real-World Evidence (RWE) Evidence. Value in Health. 2023;27(12):S545. DOI: 10.1016/j.jval.2023.09.2933 

  2. Liu J, Buer A, Rizzo M, Sarri G, Forsythe A. HTA63 The Data Lifecycle: Towards a Standardized Relational Data Model to Support Living Systematic Literature Reviews? – Use Case Demonstration with LiveSLR®. Value in Health. 2023;26(6):S270. DOI: 10.1016/j.jval.2023.03.1492 

  3. Liu J, Jafar R, Girard LA, Thorlund K, Forsythe A. MSR8 Update on the LIVESTART™ Artificial Intelligence (AI) Systematic Literature Review (SLR) Tool – Can It Aid in Limited Data Extraction for LIVEREF™? Value in Health. 2023;26(6):S279. DOI: 10.1016/j.jval.2023.03.1544 

  4. Liu J, Jafar R, Girard LA, Thorlund K, Forsythe A. MSR33 Re-Training of the Artificial Intelligence (AI) Tool LIVESTART™ with Additional Datasets: Updated Accuracy in the Title and Abstract Review Stage of Systematic Literature Reviews (SLR). Value in Health. 2023;26(6):S283-S284. DOI:  10.1016/j.jval.2023.03.1569 

  5. He C, Ammann E, Forsythe A. CO141 Using LiveSLR platform to evaluate the impact of Duration of Treatment (DOT) on Progression Free Survival (PFS) in Multiple Myeloma (MM). Value in Health. 2022;25(12):S45. DOI: 10.1016/j.jval.2022.09.218 

  6. Liu J, Verhoek A, Thorlund K, Heeg B, Sarri G, Forsythe A. HTA35 Should Health Technology Assessment (HTA) Bodies Utilize Living HTA Tools? Validation of LiveSLR® and LiveNMA™ Tools Using ICER’S Class Review in Relapsed Refractory Multiple Myeloma (RRMM). Value in Health. 2022;25(12):S302-S303. DOI: 10.1016/j.jval.2022.09.1495 

  7. Egunsola O, Verhoek A, Liu J, Thorlund K, Heeg B, Kwon C, Forsythe A. HTA145 Living Network Meta-Analysis for Up-to-Date Comparative Effectiveness: A Case Study in Multiple Myeloma Maintenance. Value in Health. 2022;25(12):S325. DOI: 10.1016/j.jval.2022.09.1603 

  8. He C, Chen Z, Kwon C, Musat M, Liu J, Sarri G, Forsythe A. HTA199 The Reality of Living Systematic Literature Reviews (SLRs) to Support Timely Healthcare Decisions: A Case Study in Relapsed/Refractory Multiple Myeloma. Value in Health. 2022;25(12):S335 DOI: 10.1016/j.jval.2022.09.1657 

  9. Liu J, Jafar R, Girard L.A, Thorlund K, Forsythe A. MSR74 Can Artificial Intelligence (AI) Replace a Human Reviewer in Systematic Literature Review (SLR)? Validation of LIVESTART™ Tool. Value in Health. 2022;25(12):S364. DOI: 10.1016/j.jval.2022.09.1805 

  10. Moreau A, Richard ME, Harricharan S, Forsythe A. POSC421 Understanding the Impact of Congress Abstracts on Overall Publications in Multiple Myeloma (MM) – Results of a Systematic Literature Review (SLR). Value in Health. 2022;25(1):S275-S276. DOI: 10.1016/j.jval.2021.11.1341 

  11. Moreau A, Richard ME, Harricharan S, Forsythe A. POSC422 The Impact of Congress Abstracts on Overall Publications in Acute Myeloid Leukemia (AML): Results of a Systematic Literature Review. Value in Health. 2022;25(1):S276. DOI:
    10.1016/j.jval.2021.11.1342 

  12. Richard ME, Harricharan S, Forsythe A. PCN291 Always up-to-Date Systematic Literature Reviews (SLRS) NOW a Reality – an Example in NEWLY Diagnosed ACUTE Myeloid Leukemia (ND AML) and Relapsed/Refractory ACUTE Lymphoblastic Leukemia (RR ALL). Value in Health. 2020;23(Suppl 2):S473. DOI: 10.1016/j.jval.2020.08.428 

  13. Hearnden J, Dudoit K, Kim E, Tremblay G, Forsythe A. PMU118 Use of computer-assisted methods to realize the concept of a living systematic review via an online platform. Value in Health. 2019;22(Suppl 3):S729. DOI: 10.1016/j.jval.2019.09.1736 

  14. Forsythe A, Hearnden J, Dudoit K, Crotty C, Tremblay G. PCN243 Real-time systematic literature reviews (SLR) – Dream or reality with computer-assisted methods: A case study in acute myeloid leukemia (AML). Value in Health. 2019;22(Suppl 2):S102. DOI: 10.1016/j.jval.2019.04.364 

Login

Edge

For physicians seeking patient-level treatment guidance and KOLs shaping the next generation of standards of care.
Log in to Edge

Enterprise

For pharmaceutical innovators to support strategic decisions and regulatory & reimbursement submissions.
Log in to Enterprise